BChE inhibition can restore cholinergic signaling and may limit amyloid aggregation, while Nrf2 activation strengthens antioxidant defenses, suppresses neuroinflammation and protects against ferroptosis. Simultaneous modulation of these pathways is therefore expected to provide broader neuroprotection than single-target approaches and may better address the multifactorial nature of AD.